The FDA has granted Gilead’s remdesivir orphan drug designation as a potential treatment for COVID-19.
Source: Devices & Diagnostics Letter
The FDA has granted Gilead’s remdesivir orphan drug designation as a potential treatment for COVID-19.
Source: Devices & Diagnostics Letter